Combined Consensus Error Grid As previously discussed in this article, I have been wearing the Libre 3, Dexcom G6 and G7, to compare performance across all three. These are the results. These are laid out showing the Consensus Error Grid for each device and all three together followed by tables providing data about the BIAS, … Read more
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, I thought it worth while in taking a quick look at the Libre3, and it’s much vaunted accuracy data. “But that’s quite a cynical title”, you might be saying to … Read more
It’s finally here. The Dexcom G7 has landed. And now it’s time for us here at Diabettech to pitch it against Abbott’s Freestyle Libre 3. Both these devices have been circulating for some time, amid mounting excitement amongst a reasonable portion of the diabetes community, as published data suggests a better user experience. We’ll be … Read more
Six months ago now, NICE launched the updated NG17 guidelines for adults with type 1 diabetes that contained the details of CGM for all users. Over the course of the next six months, multiple vendors launched cut price CGM systems that were acceptable to the NHS Business Services Authority and wound their way onto the … Read more
Going back to the summer of last year, we rolled out an initial version of DynamicISF, based on user data gathered by Chris Wilson, and submitted to the Dev branch of AndroidAPS, where it has been working, alongside a version in FreeAPSX. Most of the details of that were discussed in this post. Since the … Read more
There’s a lot of discussion around the new rtCGMs being available on prescription, but local GPs saying that they aren’t or telling you there’s nothing they can do. Most people with diabetes have a reasonably good relationship with their GP, and therefore should be able to have a conversation on a reasonable level regarding the … Read more
With the past 18 months or working on Boost and using it, various patterns have shown their heads. In the past I’ve written about the “hangover” effects of weight training and insulin sensitivity, and this past summer of participating in the 1mn steps challenge has provided an alternative view of how insulin sensitivity works in … Read more
London. A city of 10 million people, 32 boroughs, five Integrated care systems (ICS), and probably 66,000 people with type 1 diabetes. London. Also a city with a Diabetes Clinical Network and a procurement partnership. Two NHS meta-organisations designed to improve collaboration across boroughs and ICSs. NICE guidelines that say that anyone with type 1 … Read more
If you’re on Social Media, and follow diabetes, you can’t fail to have seen the noise from GlucoRX and the JDRF about BioXensor, a new, non-invasive Continuous Glucose Monitor (NICGM). While there’re plenty of exciting soundbytes relating to this brand new products, as is often the case with NICGM, there’s not a lot of detail. … Read more
Comparing Dexcom’s One with Libre2 Having had the Libre2 fall off during the first few hours of the “Six of the Best” test, I decided to run One Vs Libre2 (the two cost neutral options on the NHS Drug Tariff) head to head against one another. In this case, I used the Librelink software to … Read more